New Crohn's Disease Findings from Eli Lilly and Company Described (Exit Interviews Exploring Patients' Experience of Change in Crohn's Disease Symptoms During the Mirikizumab Phase 3 Clinical Trial In Adult Patients With Moderately-to-Severely ...)

Media coverage

• Title	New Crohn's Disease Findings from Eli Lilly and Company Described (Exit Interviews Exploring Patients' Experience of Change in Crohn's Disease Symptoms During the Mirikizumab Phase 3 Clinical Trial In Adult Patients With Moderately-to-Severely ...)
  Media name/outlet	Clinical Trials Daily
  Country/Territory	United States
  Date	5/02/25
  Persons	Marla Dubinsky